Related Experiment Video
Updated: Jun 26, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 11, 2015
Tobacco use as contributory factor in peptic ulcer disease
1Department of Medicine, Postgraduate Medical Institute, Lady Reading Hospital, Peshawar. rahmanafridi@hotmail.com
Objective:
To find out the association of tobacco as a contributory factor in patients presenting with peptic ulcer disease (PUD).
Design:
A descriptive case study.
Place And Duration Of Study:
Department of Medicine, Postgraduate Medical Institute, Lady Reading Hospital, Peshawar, from May 2001 to April 2002.
Subjects And Methods:
A total number of 100 consecutive patients, 76 males and 24 females, with endoscopically proven peptic ulcer were enrolled in the study. The ages of the patients ranged from 25 to 70 years; with mean age of 48 years + 12.26 standard deviations, (mean age of men 49 years + 12.88 SD, and mean age of women 45 years + 9.67 SD). All the patients underwent endoscopy after an overnight fast, using lignocaine (4% solution or jelly) as topical anaesthetic, with Pentax FG29 video-endoscope.
Results:
Fifty-six percent of all the patients with PUD used tobacco, 33% as cigarette, 18% took it as naswar and 5% of patients used it in both the forms. Of these, 85.7% (48/56) patients had duodenal ulcer and 14.3% (8/56) patients had gastric ulcer. All these patients were male, none of the female patients used tobacco in any form. Moreover, 40% of PUD patients reported long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).
Conclusion:
This study supports the view that use of tobacco is associated with PUD in men.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease I: Introduction

